Skip to NavigationSkip to content

News

Check out the five biggest COVID-19 stories of the past week.
Specifically, the decision relates to those in need of systemic therapy, or with advanced or metastatic RET fusion-positive thyroid cancer who also...
The approval relates to adult patients for whom prior disease-modifying antirheumatic drug (DMARD) therapy was not successful.
Ovid said it is continuing to monitor the trial for efficacy in its secondary endpoints, which include measures of sleep, communication, motor...
The vaccine is due to be rolled out via the NHS as early as next week, with an estimated 800,000 doses expected to be available. The UK has reserved...
As always, the publication features three key therapeutic areas; this edition focuses on Infectious Diseases, Rare Disease, and Respiratory.
The partnership aims to leverage Wren’s network kinetics drug discovery platform, specially designed for misfolding diseases, to develop novel small...
Hopes are high for Pfizer and BioNTech’s vaccine after it recently demonstrated 95% efficacy in global Phase 3 trials, with this efficacy...
Upon closing of the deal expected in the first quarter of next year, Grünenthal will make an upfront payment of $320 million to AZ, with further...
With globally scalable solutions that meet the strictest regulatory and industry standards, Avantor Clinical Services provides you with end-to-end...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches